SectorPharmaceutical
Established Date--
Listing Date29/03/2018
ExchangeNASDAQ Stock Exchange
Full-time Employees205
Fiscal Year Ends31/12
Security TypeCommon stock
Office address275 Wyman Street, 3rd Floor, Waltham, Massachusetts 02451
Business
IntroductionCogent Biosciences, Inc., was founded in Delaware. The company is a biotechnology company that develops precision therapies for genetic diseases. Cogent's most advanced product, PLX 9486, is a highly selective tyrosine kinase inhibitor designed to effectively inhibit KIT D816V mutations and other mutations in KIT exon 17. KITD816V can cause a rare and serious disease called systemic mastocytosis.
